Jan 12, 2026 07:16AM Stifel: 'REGN Announcements Validate APGE Thesis'

Jan 7, 2026 10:17AM Apogee Therapeutics (APGE) call put ratio 3 calls to 1 put

Jan 7, 2026 09:14AM Apogee Therapeutics Inc (APGE) PT Raised to $116 at Craig-Hallum

Jan 7, 2026 01:10AM UBS Starts Apogee Therapeutics Inc (APGE) at Buy

Jan 6, 2026 04:35PM Wolfe Research Starts Apogee Therapeutics Inc (APGE) at Peerperform

Jan 6, 2026 10:16AM RBC on Apogee Therapeutics Inc (APGE): 'we remain bullish on APGE's outlook'

Jan 6, 2026 10:12AM Apogee Therapeutics Inc (APGE) PT Raised to $137 at BTIG

Dec 29, 2025 02:35PM BTIG on Apogee (APGE): 'DUPLEX-AD's Failure is Likely a Clearing Event for APG279 and APG777 in Atopic Dermatitis'

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 16, 2025 04:20PM Stephens Starts Apogee Therapeutics Inc (APGE) at Overweight

Dec 10, 2025 12:24AM Deutsche Bank Starts Apogee Therapeutics Inc (APGE) at Buy

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 3, 2025 09:48AM Craig-Hallum Starts Apogee Therapeutics Inc (APGE) at Buy

Nov 3, 2025 08:51AM Apogee Therapeutics Inc (APGE) PT Raised at RBC Capital on Pipeline Potential

Oct 20, 2025 04:04PM Mizuho Starts Apogee Therapeutics Inc (APGE) at Outperform

Oct 9, 2025 01:22PM Apogee Therapeutics Inc (APGE) PT Lowered to $82 at BofA Securities

Oct 8, 2025 04:46PM After-hours movers: Costco, AZZ, Richardson Electronics, Apogee

Oct 8, 2025 02:56PM Apogee Therapeutics (APGE) 2400 contracts of April 50 calls trade

Sep 25, 2025 03:03AM RBC Capital Starts Apogee Therapeutics Inc (APGE) at Outperform

Aug 11, 2025 11:57AM Goldman Sachs Reiterates Early-Stage Biotech Rating on Apogee Therapeutics Inc (APGE)

Jul 10, 2025 07:24AM Stifel Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Jul 8, 2025 06:56AM Apogee Therapeutics Inc (APGE) PT Raised to $96 at Jefferies

Jul 8, 2025 06:44AM Canaccord Genuity Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Jul 7, 2025 02:02PM Citi Defending Apogee Therapeutics Inc (APGE): 'we are buyers on weakness'

Jul 7, 2025 06:00AM Apogee Therapeutics (APGE) reports positive atopic dermatitis trial results for APG777

Jul 2, 2025 06:12AM Guggenheim Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Jun 20, 2025 07:20AM Stifel Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Jun 11, 2025 09:32AM TD Cowen: 'Own Apogee Therapeutics Inc (APGE)'

May 27, 2025 09:49AM Stifel Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

May 14, 2025 06:58AM Canaccord Genuity Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

May 12, 2025 02:00PM BTIG Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

May 12, 2025 06:50AM Apogee Therapeutics (APGE) Announces Positive Interim Results from the Phase 1b Trial of APG808

May 7, 2025 10:19AM Stifel Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Mar 10, 2025 02:16PM TD Cowen Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Mar 3, 2025 11:15AM Apogee Therapeutics Inc (APGE) PT Raised to $86 at Jefferies

Mar 3, 2025 06:20AM Apogee Therapeutics (APGE) Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial

Dec 12, 2024 06:20AM Guggenheim Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Nov 27, 2024 06:07AM Apogee Therapeutics Inc (APGE) PT Raised to $110 at Guggenheim, Best Idea reiterated

Nov 12, 2024 01:43PM Stifel Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Oct 24, 2024 08:02AM Apogee Therapeutics (APGE) Announces Results Up to 9 Months from Phase 1 Trial of APG777

Sep 30, 2024 06:11AM Guggenheim Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Sep 30, 2024 05:44AM BTIG Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Sep 9, 2024 07:01AM Apogee Therapeutics (APGE) Appoints Jeff S. Hartness as CCO

Aug 20, 2024 06:06AM BTIG Reiterates Buy Rating on Apogee Therapeutics Inc (APGE)

Aug 19, 2024 07:02AM Apogee Therapeutics (APGE) Announces First Participants Dosed in Phase 1 Clinical Trial of APG990

Aug 12, 2024 06:31AM Apogee Therapeutics (APGE) Reports Q2, Provides Pipeline Update

Jul 18, 2024 08:06AM NewAmsterdam Pharma (NAMS) Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors